Comment évaluer l'efficacité de la colle de fibrine ?
L'efficacité est évaluée par l'observation de la cicatrisation et la réduction des hémorragies.
CicatrisationHémorragie
#2
Quels tests sont utilisés avant l'application ?
Des tests de coagulation sanguine peuvent être réalisés pour évaluer la compatibilité.
CoagulationTests de laboratoire
#3
Y a-t-il des contre-indications à son utilisation ?
Oui, les allergies aux composants de la colle ou des troubles de la coagulation sont des contre-indications.
AllergiesTroubles de la coagulation
#4
Comment détecter une réaction allergique ?
Une réaction allergique peut se manifester par des rougeurs, démangeaisons ou gonflements au site d'application.
Réaction allergiqueDermatite
#5
Quels signes indiquent une mauvaise cicatrisation ?
Des signes comme une inflammation persistante, une déhiscence ou une infection peuvent indiquer une mauvaise cicatrisation.
InfectionDéhiscence
Symptômes
5
#1
Quels symptômes peuvent apparaître après l'application ?
Des rougeurs, gonflements ou douleurs au site d'application peuvent survenir.
DouleurInflammation
#2
Comment reconnaître une infection post-opératoire ?
Une infection peut se manifester par une chaleur, une douleur accrue, ou un écoulement purulent.
InfectionÉcoulement purulent
#3
Y a-t-il des effets secondaires fréquents ?
Les effets secondaires peuvent inclure des démangeaisons ou des réactions au site d'application.
Effets secondairesRéaction cutanée
#4
Quels signes d'allergie doivent alerter ?
Des symptômes comme des éruptions cutanées, des démangeaisons ou un œdème peuvent indiquer une allergie.
AllergieŒdème
#5
Peut-on avoir des douleurs persistantes ?
Oui, des douleurs persistantes peuvent survenir, nécessitant une évaluation médicale.
DouleurÉvaluation médicale
Prévention
5
#1
Comment prévenir les infections après application ?
Maintenir une bonne hygiène et suivre les instructions post-opératoires aide à prévenir les infections.
HygiènePrévention des infections
#2
Quelles précautions prendre avant l'application ?
Évaluer les allergies et les antécédents médicaux est essentiel avant l'application.
AllergiesAntécédents médicaux
#3
Comment éviter les réactions allergiques ?
Un test cutané préalable peut aider à identifier les allergies potentielles aux composants.
Réaction allergiqueTest cutané
#4
Y a-t-il des recommandations pour les patients ?
Les patients doivent suivre les conseils médicaux et signaler tout symptôme inhabituel.
Conseils médicauxSymptômes
#5
Quels facteurs de risque doivent être surveillés ?
Les antécédents d'allergies et les troubles de la coagulation sont des facteurs de risque importants.
Facteurs de risqueTroubles de la coagulation
Traitements
5
#1
Comment la colle de fibrine est-elle appliquée ?
Elle est généralement appliquée par pulvérisation ou en gouttes sur les tissus à unir.
ApplicationChirurgie
#2
Quels types de blessures peuvent être traités ?
Elle est utilisée pour des coupures, des incisions chirurgicales ou des lésions cutanées.
CoupuresLésions cutanées
#3
La colle de fibrine remplace-t-elle les sutures ?
Elle peut remplacer les sutures dans certains cas, mais n'est pas toujours appropriée.
SuturesChirurgie
#4
Quels soins sont nécessaires après application ?
Il est important de garder la zone propre et sèche, et de surveiller les signes d'infection.
Soins post-opératoiresInfection
#5
Peut-on utiliser la colle de fibrine en cas d'infection ?
Non, son utilisation est contre-indiquée en présence d'une infection active.
InfectionContre-indication
Complications
5
#1
Quelles complications peuvent survenir ?
Des complications comme des infections, des réactions allergiques ou une mauvaise cicatrisation peuvent survenir.
ComplicationsInfection
#2
Comment gérer une réaction allergique ?
En cas de réaction allergique, il est crucial de consulter un médecin immédiatement.
Réaction allergiqueConsultation médicale
#3
Quels signes d'infection nécessitent une attention médicale ?
Des rougeurs, chaleur, douleur accrue ou écoulement purulent nécessitent une attention médicale.
InfectionÉcoulement purulent
#4
Peut-on avoir des cicatrices après utilisation ?
Oui, des cicatrices peuvent se former, surtout si la cicatrisation est compromise.
CicatricesCicatrisation
#5
Quelles sont les conséquences d'une mauvaise application ?
Une mauvaise application peut entraîner des déhiscences, infections ou cicatrisation inadéquate.
DéhiscenceCicatrisation
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les allergies, les troubles de la coagulation et les infections antérieures sont des facteurs de risque.
Facteurs de risqueAllergies
#2
Les personnes âgées sont-elles plus à risque ?
Oui, les personnes âgées peuvent avoir un risque accru de complications lors de l'utilisation.
Personnes âgéesComplications
#3
Les maladies chroniques influencent-elles le risque ?
Oui, des maladies comme le diabète peuvent augmenter le risque d'infection et de mauvaise cicatrisation.
Maladies chroniquesDiabète
#4
Comment le tabagisme affecte-t-il le risque ?
Le tabagisme peut retarder la cicatrisation et augmenter le risque d'infections.
TabagismeCicatrisation
#5
Les antécédents chirurgicaux augmentent-ils le risque ?
Oui, des antécédents de complications chirurgicales peuvent augmenter le risque lors de nouvelles interventions.
Antécédents chirurgicauxComplications
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Colle de fibrine : Questions médicales les plus fréquentes",
"headline": "Colle de fibrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Colle de fibrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-07",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Colle de fibrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Fibrine",
"url": "https://questionsmedicales.fr/mesh/D005337",
"about": {
"@type": "MedicalCondition",
"name": "Fibrine",
"code": {
"@type": "MedicalCode",
"code": "D005337",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.124.270"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Colle de fibrine",
"alternateName": "Fibrin Tissue Adhesive",
"code": {
"@type": "MedicalCode",
"code": "D015718",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sarah J Wu",
"url": "https://questionsmedicales.fr/author/Sarah%20J%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA."
}
},
{
"@type": "Person",
"name": "Xuanhe Zhao",
"url": "https://questionsmedicales.fr/author/Xuanhe%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA."
}
},
{
"@type": "Person",
"name": "Qian Li",
"url": "https://questionsmedicales.fr/author/Qian%20Li",
"affiliation": {
"@type": "Organization",
"name": "National Center for International Research of Micro-Nano Molding Technology, 12636Zhengzhou University, Zhengzhou, China."
}
},
{
"@type": "Person",
"name": "Yang Li",
"url": "https://questionsmedicales.fr/author/Yang%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China."
}
},
{
"@type": "Person",
"name": "Fernando Campos",
"url": "https://questionsmedicales.fr/author/Fernando%20Campos",
"affiliation": {
"@type": "Organization",
"name": "Department of Histology and Tissue Engineering Group, Faculty of Medicine, University of Granada, Granada, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Redefining Health Care Data Interoperability: Empirical Exploration of Large Language Models in Information Exchange.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38819879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/56614"
}
},
{
"@type": "ScholarlyArticle",
"name": "Building consensus on common features and interoperability use cases for community health information systems: a Delphi study.",
"datePublished": "2024-04-24",
"url": "https://questionsmedicales.fr/article/38663904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjgh-2023-014001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Towards an Interoperability Landscape for a National Research Data Infrastructure for Personal Health Data.",
"datePublished": "2024-07-13",
"url": "https://questionsmedicales.fr/article/39003329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41597-024-03615-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Making Science Computable Using Evidence-Based Medicine on Fast Healthcare Interoperability Resources: Standards Development Project.",
"datePublished": "2024-06-25",
"url": "https://questionsmedicales.fr/article/38916936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/54265"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Evolution of Health Information Technology for Enhanced Patient-Centric Care in the United States: Data-Driven Descriptive Study.",
"datePublished": "2024-10-28",
"url": "https://questionsmedicales.fr/article/39466303",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/59791"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines du sang",
"item": "https://questionsmedicales.fr/mesh/D001798"
},
{
"@type": "ListItem",
"position": 5,
"name": "Fibrine",
"item": "https://questionsmedicales.fr/mesh/D005337"
},
{
"@type": "ListItem",
"position": 6,
"name": "Colle de fibrine",
"item": "https://questionsmedicales.fr/mesh/D015718"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Colle de fibrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Colle de fibrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Colle de fibrine",
"description": "Comment évaluer l'efficacité de la colle de fibrine ?\nQuels tests sont utilisés avant l'application ?\nY a-t-il des contre-indications à son utilisation ?\nComment détecter une réaction allergique ?\nQuels signes indiquent une mauvaise cicatrisation ?",
"url": "https://questionsmedicales.fr/mesh/D015718?mesh_terms=Health+Information+Interoperability#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Colle de fibrine",
"description": "Quels symptômes peuvent apparaître après l'application ?\nComment reconnaître une infection post-opératoire ?\nY a-t-il des effets secondaires fréquents ?\nQuels signes d'allergie doivent alerter ?\nPeut-on avoir des douleurs persistantes ?",
"url": "https://questionsmedicales.fr/mesh/D015718?mesh_terms=Health+Information+Interoperability#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Colle de fibrine",
"description": "Comment prévenir les infections après application ?\nQuelles précautions prendre avant l'application ?\nComment éviter les réactions allergiques ?\nY a-t-il des recommandations pour les patients ?\nQuels facteurs de risque doivent être surveillés ?",
"url": "https://questionsmedicales.fr/mesh/D015718?mesh_terms=Health+Information+Interoperability#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Colle de fibrine",
"description": "Comment la colle de fibrine est-elle appliquée ?\nQuels types de blessures peuvent être traités ?\nLa colle de fibrine remplace-t-elle les sutures ?\nQuels soins sont nécessaires après application ?\nPeut-on utiliser la colle de fibrine en cas d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D015718?mesh_terms=Health+Information+Interoperability#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Colle de fibrine",
"description": "Quelles complications peuvent survenir ?\nComment gérer une réaction allergique ?\nQuels signes d'infection nécessitent une attention médicale ?\nPeut-on avoir des cicatrices après utilisation ?\nQuelles sont les conséquences d'une mauvaise application ?",
"url": "https://questionsmedicales.fr/mesh/D015718?mesh_terms=Health+Information+Interoperability#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Colle de fibrine",
"description": "Quels sont les principaux facteurs de risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes maladies chroniques influencent-elles le risque ?\nComment le tabagisme affecte-t-il le risque ?\nLes antécédents chirurgicaux augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015718?mesh_terms=Health+Information+Interoperability#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité de la colle de fibrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'observation de la cicatrisation et la réduction des hémorragies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés avant l'application ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de coagulation sanguine peuvent être réalisés pour évaluer la compatibilité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des contre-indications à son utilisation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les allergies aux composants de la colle ou des troubles de la coagulation sont des contre-indications."
}
},
{
"@type": "Question",
"name": "Comment détecter une réaction allergique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une réaction allergique peut se manifester par des rougeurs, démangeaisons ou gonflements au site d'application."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une mauvaise cicatrisation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une inflammation persistante, une déhiscence ou une infection peuvent indiquer une mauvaise cicatrisation."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après l'application ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs, gonflements ou douleurs au site d'application peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection post-opératoire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection peut se manifester par une chaleur, une douleur accrue, ou un écoulement purulent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des démangeaisons ou des réactions au site d'application."
}
},
{
"@type": "Question",
"name": "Quels signes d'allergie doivent alerter ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des éruptions cutanées, des démangeaisons ou un œdème peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs persistantes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs persistantes peuvent survenir, nécessitant une évaluation médicale."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections après application ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et suivre les instructions post-opératoires aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant l'application ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les allergies et les antécédents médicaux est essentiel avant l'application."
}
},
{
"@type": "Question",
"name": "Comment éviter les réactions allergiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test cutané préalable peut aider à identifier les allergies potentielles aux composants."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les patients ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients doivent suivre les conseils médicaux et signaler tout symptôme inhabituel."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque doivent être surveillés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies et les troubles de la coagulation sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "Comment la colle de fibrine est-elle appliquée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement appliquée par pulvérisation ou en gouttes sur les tissus à unir."
}
},
{
"@type": "Question",
"name": "Quels types de blessures peuvent être traités ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est utilisée pour des coupures, des incisions chirurgicales ou des lésions cutanées."
}
},
{
"@type": "Question",
"name": "La colle de fibrine remplace-t-elle les sutures ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut remplacer les sutures dans certains cas, mais n'est pas toujours appropriée."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après application ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important de garder la zone propre et sèche, et de surveiller les signes d'infection."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la colle de fibrine en cas d'infection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, son utilisation est contre-indiquée en présence d'une infection active."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections, des réactions allergiques ou une mauvaise cicatrisation peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de réaction allergique, il est crucial de consulter un médecin immédiatement."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection nécessitent une attention médicale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs, chaleur, douleur accrue ou écoulement purulent nécessitent une attention médicale."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des cicatrices après utilisation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cicatrices peuvent se former, surtout si la cicatrisation est compromise."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une mauvaise application ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise application peut entraîner des déhiscences, infections ou cicatrisation inadéquate."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les allergies, les troubles de la coagulation et les infections antérieures sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru de complications lors de l'utilisation."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent augmenter le risque d'infection et de mauvaise cicatrisation."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme affecte-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut retarder la cicatrisation et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les antécédents chirurgicaux augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de complications chirurgicales peuvent augmenter le risque lors de nouvelles interventions."
}
}
]
}
]
}
Department of Thoracic and Cardiovascular Surgery, Sapporo Medical University School of Medicine, Sapporo, 060-8543, Japan.
Department of Material-Based Medical Engineering, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, 101-0023, Japan.
Department of Material-Based Medical Engineering, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, 101-0023, Japan.
Department of Material-Based Medical Engineering, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, 101-0023, Japan.
College of Materials Science and Engineering, Wuhan Textile University, Wuhan 430073, People's Republic of China.
Key Laboratory of Green Processing and Functional Textiles of New Textile Materials, Ministry of Education, Wuhan Textile University, Wuhan 430073, People's Republic of China.
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.
Department of Normal and Topographic Anatomy, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University (MSU), 31-5 Lomonosovsky Prospekt, 117192 Moscow, Russian Federation.
Efficient data exchange and health care interoperability are impeded by medical records often being in nonstandardized or unstructured natural language format. Advanced language models, such as large ...
This study aims to evaluate the capability of LLMs in transforming and transferring health care data to support interoperability....
Using data from the Medical Information Mart for Intensive Care III and UK Biobank, the study conducted 3 experiments. Experiment 1 assessed the accuracy of transforming structured laboratory results ...
The text-based approach showed a high conversion accuracy in transforming laboratory results (experiment 1) and an enhanced consistency in diagnostic code conversion, particularly for frequently used ...
This study highlighted the potential role of LLMs in significantly improving health care data interoperability, demonstrated by their high accuracy and efficiency in data transformation and exchange. ...
Information systems for community health have become increasingly sophisticated and evidence-based in the last decade and they are now the most widely used health information systems in many low-incom...
A Delphi study was conducted among a systematically selected panel of CHIS experts. This impressive pool of experts represented a range of leading global health institutions, with gender and regional ...
CHISs today are expected to adapt to a wide range of local contextual requirements and to support and improve care delivery. While once associated with a single role type (CHWs), these systems are now...
CHISs today are expected to be feature-rich, to support a range of user roles in community health systems, and to be highly adaptable to local contextual requirements. Future interoperability efforts,...
The German initiative "National Research Data Infrastructure for Personal Health Data" (NFDI4Health) focuses on research data management in health research. It aims to foster and develop harmonized in...
Evidence-based medicine (EBM) has the potential to improve health outcomes, but EBM has not been widely integrated into the systems used for research or clinical decision-making. There has not been a ...
This study aimed to introduce the EBM on Fast Healthcare Interoperability Resources (FHIR) project (EBMonFHIR), which is extending the methods and infrastructure of Health Level Seven (HL7) FHIR to pr...
As an ongoing process, the project creates and refines FHIR resources to represent evidence from clinical studies and syntheses of those studies and develops tools to assist with the creation and visu...
The EBMonFHIR project created FHIR resources (ie, ArtifactAssessment, Citation, Evidence, EvidenceReport, and EvidenceVariable) for representing evidence. The COVID-19 Knowledge Accelerator (COKA) pro...
EBMonFHIR resources in conjunction with other FHIR resources can support relaying EBM components in a manner that is interoperable and consumable by downstream tools and health information technology ...
Health information technology (health IT) has revolutionized health care in the United States through interoperable clinical care data exchange, e-prescribing, electronic public health reporting, and ...
This study aims to examine progress in health IT adoption and its alignment with the Office of the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT (ASTP's) m...
This study leverages data on end users of health IT to capture trends in engagement in interoperable clinical care data exchange (ability to find, send, receive, and integrate information from outside...
Since 2009, there has been a 10-fold increase in electronic health record (EHR) use among hospitals and a 5-fold increase among physicians. This enabled the interoperable exchange of electronic health...
Federal incentives have contributed to the widespread adoption of EHRs and broad digitization in health care, while efforts to promote interoperability have encouraged collaboration across health care...
Reaching meaningful interoperability between proprietary health care systems is a ubiquitous task in medical informatics, where communication servers are traditionally used for referring and transform...
In this study, a generic approach is developed, which allows for the application of declarative mapping rules defined using FML in an exchangeable manner. A transformation engine is required to execut...
FHIR natively defines resources to support the conversion of instance data, such as an FHIR StructureMap. This resource encodes all information required to transform data from a source system to a tar...
The resulting tool is called FML2Mirth, a Java-based transformer that derives Mirth channels from detailed declarative mapping rules based on the underlying StructureMaps. Implementation of the transl...
The tool for the auto-generation of Mirth channels was successfully presented. Our tests reveal the feasibility of using the complex structures of the mapping language in combination with a terminolog...
The lack of interoperability between health information systems reduces the quality of care provided to patients and wastes resources. Accordingly, there is an urgent need to develop integration mecha...
In accordance with the PRISMA guideline, a broad electronic search of all literature was conducted on the topic through six databases, including PubMed, Web of science, Scopus, MEDLINE, Cochrane Libra...
Interoperability has been raised in the field of health information systems from 2003 and now it is one of the topics of interest to researchers. The projects done in this field are mostly in the nati...
The health industry has become more complex and has new needs. Interoperability meets this needs by communicating between the output and input of processor systems and making easier to access the data...
Enabling widespread interoperability-the ability of health information technology systems to exchange information and to use that information without special effort-is a primary focus of public policy...
To assess primary care physician perspectives on the state of interoperability....
A cross-sectional survey of family medicine physicians in the US was conducted from December 12, 2021, to October 12, 2022. A sample of family medicine physicians who completed the Continuous Certific...
Eighteen items on the CCQ assessed experience accessing and using various information from outside organizations, including medications, immunizations, and allergies....
A total of 2088 physicians (1053 women [50%]; age reported categorically as either ≥50 years or <50 years) completed the CCQ interoperability questions in 2022. Of these respondents, 35% practiced in ...
This survey study of family medicine physicians found modest and uneven improvement in physicians' experience with interoperability. These findings suggest that substantial heterogeneity in satisfacti...
To review recent literature on health information exchange (HIE), focusing on the policy approach of five case study nations: the United States of America, the United Kingdom, Germany, Israel, and Por...
A narrative review of each nation's HIE policy frameworks, current state, and future HIE strategy....
Key themes that emerged include the importance of both central decision-making as well as local innovation, the multiple and complex challenges of broad HIE adoption, and the varying role of HIE acros...
HIE is an increasingly important capability and policy priority as electronic health record (EHR) adoption becomes more common and care delivery is increasingly digitized. While all five case study na...
High levels of seamless, bidirectional health information exchange continue to be broadly limited among provider groups despite the vast array of benefits that interoperability entails for patient car...
We aimed to examine the correlation at the provider group level between the distinct directions of interoperability with regard to sending health information and receiving health information, to descr...
We used data from the Centers for Medicare & Medicaid Services (CMS), which included interoperability performance information for 2033 provider groups within the Quality Payment Program Merit-based In...
We found that the examined directions of interoperability-sending health information and receiving health information-have relatively low bivariate correlation (0.4147) with a significant number of ob...
The adoption of interoperability by provider groups is more nuanced than traditionally considered and should not be seen as a binary determination (ie, to be interoperable or not). Asymmetric interope...